XML 36 R27.htm IDEA: XBRL DOCUMENT v3.5.0.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narratives) (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Other current assets $ 325   $ 325   $ 537
Current prepaid expense 100   100    
Other current receivables 200   $ 200    
Share-based compensation arrangement by share-based payment award, expiration period     10 years    
Stock-based compensation expense     $ 119 $ 322  
Unrecognized compensation expense related to unvested stock awards, not yet recognized $ 200   $ 200    
Unvested stock options, unrecognized compensation expense weighted average recognition period     1 year 2 months 1 day    
Stock options, granted (in shares) 0   14,000 608,910  
Stock options, fair value assumptions, risk free interest rate (as a percent)     1.91%    
Stock options, fair value assumptions, dividend yield     0.00%    
Stock options, fair value assumptions, expected life     6 years    
Stock options, fair value assumptions, historical volatility rate (as a percent)     85.00%    
Common stock rights issued (in shares)     2,933,106 1,208,491  
Deferred revenue $ 111   $ 111   217
Options, warrants and conversion rights, common stock callable and antidilutive (in shares)     10,721,464 8,286,963  
Pharmacogenomic Services          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Deferred revenue 100   $ 100   $ 100
Executive Officers          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock options, unvested options, vesting period     3 years    
Common stock rights issued (in shares)     98,333    
Selling, General and Administrative Expenses          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock-based compensation expense $ 100 $ 200 $ 100 $ 300  
Maximum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock options, unvested options, vesting period     3 years